Physician profile
Stephen C Payne
NPI 1003871518
$2,310.45
in general payments reported to CMS, 2019-2025
17 companies · $14.29 in 2025
The $14.29 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,546 · 2020: $481 · 2021: $250 · 2022: $19.00 · 2025: $14.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $770.02 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $650.35 | 2019-2021 | |
| Amgen INC. | $289.12 | 2019-2020 | |
| Glaxosmithkline, LLC. | $134.52 | 2019-2020 | |
| Lilly USA, LLC | $121.41 | 2019 | |
| Astellas Pharma US INC | $68.54 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $66.40 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.69 | 2019 | |
| Sanofi-Aventis U.S. LLC | $26.80 | 2019 | |
| Sanofi Pasteur INC. | $24.31 | 2019 | |
| Pfizer INC. | $23.33 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $19.00 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.31 | 2019 | |
| Mylan Specialty L.P. | $14.71 | 2019 | |
| Dynavax Technologies Corporation | $14.29 | 2025 | Heplisav-B |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $11.56 | 2019 | |
| Merck Sharp & Dohme LLC | $11.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.